Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 312.50 | 200.50 | 406.00 | 341.75 | 1.1880 | 1.5020 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 312.50 | 200.50 | 462.00 | 341.75 | 1.3519 | 1.9595 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 200.50 | 460.00 | 341.75 | 1.3460 | 1.9429 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 312.50 | 200.50 | 244.00 | 341.75 | 0.7140 | 0.2908 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 312.50 | 200.50 | 271.00 | 341.75 | 0.7930 | 0.4794 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 342.00 | 341.75 | 1.0007 | 1.0019 | |
| SK-BR-3 | Lapatinib | 1 | uM | 9 | 312.50 | 200.50 | 292.00 | 341.75 | 0.8544 | 0.6301 |
| SK-BR-3 | Lapatinib | 10 | uM | 9 | 312.50 | 200.50 | 169.00 | 341.75 | 0.4945 | -0.1992 |
| SK-BR-3 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 200.50 | 291.00 | 341.75 | 0.8515 | 0.6229 |
| SK-BR-3 | Linsitinib | 0.1 | uM | 9 | 312.50 | 200.50 | 286.00 | 341.75 | 0.8369 | 0.5867 |
| SK-BR-3 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 200.50 | 313.00 | 341.75 | 0.9159 | 0.7841 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 200.50 | 197.00 | 341.75 | 0.5764 | -0.0226 |
| SK-BR-3 | 0 | uM | 9 | 312.50 | 200.50 | 195.00 | 341.75 | 0.5706 | -0.0355 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 689.00 | 785.00 | 0.8777 | 0.7357 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 976.00 | 785.00 | 1.2433 | 1.5340 | |
| SK-BR-3 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 937.00 | 785.00 | 1.1936 | 1.4242 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 9 | 625.00 | 414.82 | 756.00 | 785.00 | 0.9631 | 0.9198 |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 414.82 | 992.00 | 785.00 | 1.2637 | 1.5792 |
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 768.00 | 785.00 | 0.9783 | 0.9530 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 583.00 | 785.00 | 0.7427 | 0.4475 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 625.00 | 414.82 | 547.00 | 785.00 | 0.6968 | 0.3507 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 625.00 | 414.82 | 1228.00 | 785.00 | 1.5643 | 2.2524 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 1116.00 | 785.00 | 1.4217 | 1.9314 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 625.00 | 414.82 | 441.00 | 785.00 | 0.5618 | 0.0688 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 625.00 | 414.82 | 1167.00 | 785.00 | 1.4866 | 2.0772 |